EZH2 and breast cancer: Functionally, conditional ablation of EZH2 in the MTB/tetO-MIC model significantly delayed tumor onset and decreased the incidence of lung metastasis, showing that EZH2 is essential for progression of mammary tumors and metastasis [42].